Game Time: FDA Releases Review Timeline Goals Set By MDUFA V
This exclusive infographic shows new review timelines the FDA announced for FY 2023 now that MDUFA V has been ratified.
You may also be interested in...
Big Pharma At US FDA: A Regulatory Scorecard
The breakthrough designations, approvals, and rejections for applications from the 15 biggest companies in a Pink Sheet infographic.
FDA Encourages Voluntary Device Shortage Reporting After PHE End
The FDA updated its policies regarding 506J notifications for device manufacturers at the end of the public health emergency.
Digital Health Roundup: HIMSS, Cardio Conversations, ChatGPT And New FDA Guidances
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb discusses how two medtech CEOs are and aren’t using ChatGPT in their businesses while Reed Miller talks about his “Cardio Conversations” podcast interviews with Quentin Blackford, CEO of iRhythm, and Rob Krummen, CEO of Vektor Medical. Washington, DC-based reporter Hannah Daniel reviews highlights from the HIMSS conference and the latest updates on FDA guidances.